Standardizing quality criteria for liver ultrasound with contrast
Part of Digestive system clinical trials.
This trial gathers expert doctors to create standard quality rules for liver ultrasound exams that use contrast dye. If you're a very experienced ultrasound doctor, your opinion could help shape future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have at least 6 years of experience doing ultrasounds in internal medicine, radiology, or a similar field.
- You must have personally performed at least 5,000 ultrasound exams.
- You must have completed structured training in contrast-enhanced ultrasound (CEUS).
- You must perform at least 800 ultrasound exams each year in your regular practice.
- You must either do at least 100 CEUS exams per year or have done more than 700 CEUS exams in total.
- You must regularly attend ultrasound meetings, case reviews, or quality checks at your hospital.
- You must be scientifically involved in CEUS—meaning you have published at least one paper or taught CEUS courses.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special ultrasound with a contrast agent to see if it can diagnose PSVD (a rare liver vessel disorder) without a biopsy. It compares people with PSVD to those with cirrhosis to find better, noninvasive ways to detect this condition.
This trial uses a special ultrasound with contrast dye to get a clearer picture of bladder cancer before any treatment. It aims to improve how doctors determine the stage of the cancer, which helps guide the best treatment plan.
This trial tests a remote, automated ultrasound system that may allow you to get an ultrasound exam without the doctor being in the same room. The goal is to see if it works as well as a standard ultrasound and is safe to use.
This trial uses a special ultrasound with contrast dye to get a clearer picture of liver spots that other scans (CT, MRI, or PET) couldn't fully identify. The goal is to see if this ultrasound can help doctors make a more accurate diagnosis.
This trial tests whether a special ultrasound scan using contrast dye can better detect early liver cancer in people with cirrhosis (scarring of the liver). The goal is to catch liver cancer at an earlier, more treatable stage.
This trial looks at whether special features seen on contrast-enhanced ultrasound can help doctors better classify liver nodules using a system called LI-RADS. It’s for people at high risk for liver cancer who have recent imaging and clear tissue diagnosis.
Hear when a new Contrast Enhanced Ultrasound trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.